Comparison of additional intraocular pressure-lowering effects of latanoprost vs brimonidine in primary open-angle glaucoma patients with intraocular pressure uncontrolled by timolol–dorzolamide combination-Reference-Cited by-同舟云学术

Comparison of additional intraocular pressure-lowering effects of latanoprost vs brimonidine in primary open-angle glaucoma patients with intraocular pressure uncontrolled by timolol–dorzolamide combination

Published:2004-05-07 Issue:2 Volume:19 Page:145-151
ISSN:0950-222X
Container-title:Eye
language:en
Short-container-title:Eye

Author:

Akman A,Cetinkaya A,Akova Y A,Ertan A

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

http://www.nature.com/articles/6701428.pdf

Reference21 articles.

1. Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt J et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol 1991; 109: 1090–1095.

2. Kass MA, Heuer DK, Higginbotham EJ, Johnson JA, Keltner JL, Miller JP et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120: 701–713.

3. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000; 130: 429–440.

4. Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001; 108: 1943–1953.

5. Leske CM, Connell AM, Wu SY, Hyman LG, Schachat AP . Risk factors for open-angle glaucoma. The Barbados Eye Study. Arch Ophthalmol 1995; 113: 918–924.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carrageenan tethered ion sensitive smart nanogel containing oleophytocubosomes for improved ocular luteolin delivery;International Journal of Pharmaceutics;2023-11

2. Novel crosslinked nanoparticles of chitosan oligosaccharide and dextran sulfate for ocular administration of dorzolamide against glaucoma;Journal of Drug Delivery Science and Technology;2023-09

3. The Therapeutic Benefits of Nanoencapsulation in Drug Delivery to the Anterior Segment of the Eye: A Systematic Review;Frontiers in Pharmacology;2022-05-13

4. Chitosan-coated bovine serum albumin nanoparticles for topical tetrandrine delivery in glaucoma: in vitro and in vivo assessment;Drug Delivery;2022-04-06

5. Medical Management of Glaucoma;Albert and Jakobiec's Principles and Practice of Ophthalmology;2022